Needham & Company LLC Reaffirms “Buy” Rating for Boston Scientific (NYSE:BSX)
Needham & Company LLC reaffirmed their buy rating on shares of Boston Scientific (NYSE:BSX – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a $115.00 price objective on the medical equipment provider’s stock. Several other analysts have also recently issued reports on the stock. Truist Financial upped […]
Needham & Company LLC reaffirmed their buy rating on shares of Boston Scientific (NYSE:BSX – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a $115.00 price objective on the medical equipment provider’s stock. Several other analysts have also recently issued reports on the stock. Truist Financial upped […]
